ARUP’s diabetes testing combines our excellence in quality with flexible testing options to meet each unique clinical need. 

Learn more

From screening to diagnosis and monitoring, our suite of laboratory tests supports providers and patients in every stage of disease management. 

Why Choose ARUP for Diabetes Testing?

chat-communicate

Faster turnaround times and 24-hour testing capabilities enable timely and individualized treatment plans.

chat-communicate

Tests designed to meet your needs:

ARUP offers a diverse range of tests designed to cater to specific clinical requirements. Our à la carte testing options enable a tailored approach based on the nuances of each condition.

chat-communicate

Access to clinical pathology experts:

When you partner with ARUP, you gain access to our team of pathologists who specialize in genomics, endocrinology, and chemistry. Our experts contribute to academic research and literature in the field of diabetes, providing valuable insights for test selection and result interpretation.

 

For more information and decision support tools, refer to the ARUP Consult® Diabetes Mellitus - Type 1, Type 2, and Gestational topic.

Available Tests for Diabetes

Screening and Diagnosis

Screening and Diagnosis

Tests used to screen for and diagnose diabetes mellitus (DM) include:

  • Glucose, Plasma or Serum (0020024)
  • Hemoglobin A1c (0070426)
    • Our testing uses capillary electrophoresis to separate different forms of hemoglobin, which allows for a direct measurement of HbA1c. This technology is less susceptible to interference from hemoglobin variants and modified forms of hemoglobin than other methods.

Etiology

Screening and Diagnosis

Diabetes-related autoantibody testing can help to establish autoimmune etiology in individuals previously diagnosed with type 1 DM (T1DM) or to exclude a diagnosis of T1DM in adults who lack traditional risk factors.

Our single orderable tests allow you to tailor a testing combination most beneficial for your patient’s unique situation.

Molecular Analysis

Screening and Diagnosis

ARUP offers one of the most comprehensive genetic testing panels on the market that includes 23 genes to identify patients with DM for whom genetic etiology is suspected.

  1. MODY and Neonatal Diabetes Panel, Sequencing (3001593)

Additional associated tests offered by ARUP may be useful for glycemic control monitoring.

  1. 1,5 Anhydroglucitol Quantitative, Serum or Plasma (0081335)
  2. Fructosamine (0099012)

For additional testing information, please refer to our Laboratory Test Directory.

Additional Resources

chat-communicate Video Lecture: Diabetes: Don’t Sugarcoat It—Presented by Heather A. Nelson, PhD

References